Watson Pharmaceuticals, Inc. (WPI) Tops Q1 EPS by 4c; Guides FY12 Sales
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Financial Fact:
Cost of sales (excludes amortization, presented below): 1.08B
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of sales (excludes amortization, presented below): 1.08B
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q1 EPS of $1.64, $0.04 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.52 million versus the consensus estimate of $1.48 million.
Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Sees FY12 sales of $5.5 billion, versus the consensus of $5.5 billion.
For earnings history and earnings-related data on Watson Pharmaceuticals, Inc. (WPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
